alzhub.org
Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

Home › Research › Topics › promise

promise

4 studies tagged promise, dated 2017-02-01 to 2026-01-12. Bibliography: BibTeX (.bib) · RIS (.ris)

Newest in this topic

  1. Merging multimodal digital biomarkers into "Digital Neuro Fingerprints" for precision neurology in dementias: the promise of the right treatment for the right patient at the right time in the age of AI 2026-01-12
  2. Lipid metabolism and Alzheimer's disease: clinical evidence, mechanistic link and therapeutic promise 2022-01-18
  3. The clinical promise of biomarkers of synapse damage or loss in Alzheimer's disease 2020-03-02

Studies

4 studies carry this tag.

Date range

2017 to 2026

Top journals

  • Alzheimer's research & therapy 1
  • Frontiers in digital health 1
  • Molecular diagnosis & therapy 1
  • The FEBS journal 1

Newest first, then by address. Each study has a usefulness score out of 100 (rubric version 4.0); tap a score to see what makes it up. Tags were assigned automatically from each study's title and summary. The same studies as a filter in the library.

  1. Merging multimodal digital biomarkers into "Digital Neuro Fingerprints" for precision neurology in dementias: the promise of the right treatment for the right patient at the right time in the age of AI

    ✓ Peer-reviewed alzhub usefulness score 45 out of 100. Frontiers in digital health 2026-01-12 Cognitive tests and assessment

    Digital biomarkers are revolutionizing medicine in ways that were unimaginable a few years ago.

  2. Lipid metabolism and Alzheimer's disease: clinical evidence, mechanistic link and therapeutic promise

    ✓ Peer-reviewed alzhub usefulness score 40 out of 100. The FEBS journal 2022-01-18 Genetics

    Alzheimer's disease (AD) is an age-associated neurodegenerative disorder with multifactorial etiology, intersecting genetic and environmental risk factors, and a lack of disease-modifying therapeutics.

  3. The clinical promise of biomarkers of synapse damage or loss in Alzheimer's disease

    ✓ Peer-reviewed alzhub usefulness score 41 out of 100. Alzheimer's research & therapy 2020-03-02 Tau biomarkers

    A number of emerging biomarkers are able to measure synapse injury and loss in the brain and may correlate with cognitive function in AD.

  4. Blood Biomarkers for Alzheimer's Disease: Much Promise, Cautious Progress

    ✓ Peer-reviewed alzhub usefulness score 53 out of 100. Molecular diagnosis & therapy 2017-02-01 Biomarkers

    Biomarkers in Alzheimer's disease (AD) have the potential to allow early and more accurate diagnosis, predict disease progression, stratify individuals and track response to candidate therapies in drug trials.

All topic tags with their study counts